Rib Fracture Risk: Using RibScore + SCARF to Predict Decline

Rib Fracture Risk: Using RibScore + SCARF to Predict Decline

🧭 REBEL Rundown 🗝️ Key Points 🧓 Rib fractures in older adults can decompensate late — early vitals and a “normal-ish” exam don’t rule out impending respiratory decline. 🖥️ RibScore = anatomy/CT risk — helps predict pulmonary complications and supports disposition decisions (floor vs stepdown/ICU). 🫁 SCARF = bedside physiology & function — repeatable and…

Read More
SIGH35 vs. EEOT in ICU

SIGH35 vs. EEOT in ICU

What was it? A prospective study conducted in a general ICU in Milan, Italy, to assess the reliability of two haemodynamic tests, SIGH35 and end-expiratory occlusion test (EEOT), to predict fluid responsiveness in critically ill patients on PSV.  PSV creates a challenge for haemodynamic tests, as it alters heart-lung physiological interplay where the presence of some spontaneous breathing renders…

Read More
EM@3AM: Perforated Viscus – emDocs

EM@3AM: Perforated Viscus – emDocs

Authors: Nishok Victory Srivanasan, MD (EM Resident, University of Missouri-Columbia); Jailyn Avila, MD, FP-AEMUS; Jessica Pelletier, DO, MHPE (APD/Assistant Professor of EM/Attending Physician, University of Missouri-Columbia) // Reviewed by: Sophia Görgens, MD (EM Physician, Yale University, CT); Cassandra Mackey, MD (Assistant Professor of Emergency Medicine, UMass Chan Medical School); Alex Koyfman, MD (@EMHighAK); Brit Long,…

Read More
Clinical Conundrum: How Effective is Oseltamivir in Influenza? – REBEL EM

Clinical Conundrum: How Effective is Oseltamivir in Influenza? – REBEL EM

Annual influenza cases exceed one billion worldwide, with the vast majority of patients experiencing mild to moderate severity of illness. This massive health burden explains the extensive research into antivirals, including oseltamivir (Tamiflu). Initial studies supported the utility of oseltamivir for preventing complications, hospitalization and shortening disease course in patients with mild to moderate influenza….

Read More
ACEP-Endorsed SUPPORT Act Is Reauthorized

ACEP-Endorsed SUPPORT Act Is Reauthorized

The bipartisan Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Reauthorization Act of 2025 has been signed into law. This ACEP-informed and -supported legislation renews and strengthens a range of critical federal programs designed to address the intersecting mental health, opioid/substance use disorder (OUD/SUD), and overdose crises affecting millions of patients…

Read More
ACEP Now’s Top Five Articles of 2025

ACEP Now’s Top Five Articles of 2025

ACEP Now publishes a selection of content ranging from association news (i.e., what’s happening inside the College), news stories impacting the specialty of emergency medicine, medical educational content from our amazing columnists, case reports from our readers, and opinion pieces from ACEP members. Each year, we review the analytics to determine the most popular items….

Read More